PTEN and gastrointestinal stromal tumor: The transcriptional profiling in the GIST-60 cohort revealed a significantly lower PTEN expression in patients with local and metastatic relapse (n = 16) compared with those with no documented recurrence (n = 44; P = .0004; Fig 1A).